Could a simple pill let women start labor at home?
NCT ID NCT05177510
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a pill called mifepristone can safely and effectively start labor in pregnant women so they can stay home longer instead of being admitted to the hospital right away. About 400 women with a full-term, single baby and an unready cervix will take either mifepristone or a placebo. The goal is to see if more women go into labor within two days, reducing hospital stays and improving the birth experience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mifepristone
What this could lead to
If it works, this could allow many women to start labor at home instead of in the hospital, making the process shorter and more comfortable.
What could go wrong
This is a mid-stage trial with 400 participants, so results are not yet proven. The drug may not work better than placebo, and there are always risks with any medication during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR, INDUCED are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chelsea and Westminster Hospital
RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-••••